An observation study to evaluate safety and efficacy of antiplatelet drugs in patients after percutaneous coronary intervention.
Not Applicable
- Conditions
- Health Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- CTRI/2023/10/059339
- Lead Sponsor
- Pragya Hangma Subba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 18 years of age have documented administration of at least two different oral DAPT after PCI with DES implantation.
Exclusion Criteria
1. Patients with active bleeding or bleeding disorder
2. Patients with contraindications to antiplatelet therapy
3. Patients with ongoing long-term treatment with oral anticoagulants
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method